This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2006 Dec 20;24(36):5786-8.

doi: 10.1200/JCO.2006.08.6868.

Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma

Kun-Ying Tsai¹, Chih-Hsun Yang, Tseng-Tong Kuo, Hong-Shang Hong, John W C Chang

Affiliations

PMID: 17179114
DOI: 10.1200/JCO.2006.08.6868

Case Reports

Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma

Kun-Ying Tsai et al. J Clin Oncol. 2006.

. 2006 Dec 20;24(36):5786-8.

doi: 10.1200/JCO.2006.08.6868.

Authors

Kun-Ying Tsai¹, Chih-Hsun Yang, Tseng-Tong Kuo, Hong-Shang Hong, John W C Chang

Affiliation

¹ Department of Dermatology, Chang Gung Memorial Hospital and University, Taipei, Taiwan.

PMID: 17179114
DOI: 10.1200/JCO.2006.08.6868

No abstract available

PubMed Disclaimer

Similar articles

Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
Daniels GH. Daniels GH. Clin Endocrinol (Oxf). 2009 Sep;71(3):455. doi: 10.1111/j.1365-2265.2008.03499.x. Epub 2008 Dec 5. Clin Endocrinol (Oxf). 2009. PMID: 19138312 No abstract available.
Sunitinib-induced hand-foot syndrome in a renal cell carcinoma: a sclerodermatous and rheumatoid arthritis-like case.
Ohtsuka T. Ohtsuka T. J Dermatol. 2012 Nov;39(11):943-4. doi: 10.1111/j.1346-8138.2011.01486.x. Epub 2012 Jan 19. J Dermatol. 2012. PMID: 22257303 No abstract available.
Cardiotoxicity associated with sunitinib.
Hariharan S, Lowry S. Hariharan S, et al. Lancet. 2008 Apr 12;371(9620):1244-5; author reply 1245. doi: 10.1016/S0140-6736(08)60552-8. Lancet. 2008. PMID: 18406854 No abstract available.
Sorafenib and sunitinib: novel targeted therapies for renal cell cancer.
Grandinetti CA, Goldspiel BR. Grandinetti CA, et al. Pharmacotherapy. 2007 Aug;27(8):1125-44. doi: 10.1592/phco.27.8.1125. Pharmacotherapy. 2007. PMID: 17655513 Review.
Sunitinib.
Heng DY, Kollmannsberger C. Heng DY, et al. Recent Results Cancer Res. 2010;184:71-82. doi: 10.1007/978-3-642-01222-8_6. Recent Results Cancer Res. 2010. PMID: 20072832 Review.

See all similar articles

Cited by

Novel therapies in advanced renal cell carcinoma: management of adverse events from sorafenib and sunitinib.
Ivanyi P, Winkler T, Ganser A, Reuter C, Grünwald V. Ivanyi P, et al. Dtsch Arztebl Int. 2008 Mar;105(13):232-7. doi: 10.3238/arztebl.2008.0232. Epub 2008 Mar 28. Dtsch Arztebl Int. 2008. PMID: 19629201 Free PMC article.
Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.
Kollmannsberger C, Bjarnason G, Burnett P, Creel P, Davis M, Dawson N, Feldman D, George S, Hershman J, Lechner T, Potter A, Raymond E, Treister N, Wood L, Wu S, Bukowski R. Kollmannsberger C, et al. Oncologist. 2011;16(5):543-53. doi: 10.1634/theoncologist.2010-0263. Epub 2011 Apr 13. Oncologist. 2011. PMID: 21490127 Free PMC article. Review.
Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil.
Werbel T, Cohen PR. Werbel T, et al. Dermatol Ther (Heidelb). 2018 Sep;8(3):495-501. doi: 10.1007/s13555-018-0253-2. Epub 2018 Jul 26. Dermatol Ther (Heidelb). 2018. PMID: 30051297 Free PMC article.
Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects.
Kollmannsberger C, Soulieres D, Wong R, Scalera A, Gaspo R, Bjarnason G. Kollmannsberger C, et al. Can Urol Assoc J. 2007 Jun;1(2 Suppl):S41-54. doi: 10.5489/cuaj.67. Can Urol Assoc J. 2007. PMID: 18542784 Free PMC article.
Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction.
Yeh CN, Chung WH, Su SC, Chen YY, Cheng CT, Lin YL, Chang WC, Chung-Yee Hui R, Chiang KC, Chen TW, Jan YY, Chen CW, Chen TJ, Yang CH, Hung SI. Yeh CN, et al. J Invest Dermatol. 2014 Nov;134(11):2768-2775. doi: 10.1038/jid.2014.218. Epub 2014 May 6. J Invest Dermatol. 2014. PMID: 24802849

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information